Akso Health Group Sponsored ADR (NASDAQ:AHG - Get Free Report) shares saw an uptick in trading volume on Monday . 177,696 shares were traded during mid-day trading, an increase of 133% from the previous session's volume of 76,210 shares.The stock last traded at $1.9260 and had previously closed at $2.00.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Akso Health Group in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of "Sell".
Check Out Our Latest Analysis on Akso Health Group
Akso Health Group Stock Down 3.8%
The firm's 50 day simple moving average is $1.91 and its 200-day simple moving average is $1.66.
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC bought a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 16,748 shares of the company's stock, valued at approximately $27,000. 1.21% of the stock is currently owned by institutional investors and hedge funds.
About Akso Health Group
(
Get Free Report)
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Akso Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.
While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.